Showing results (1611-1620 of 5,060) with videos related to
Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|February 10, 2016
Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensionsGiancarlo Comi, Mark S Freedman, Ludwig Kappos, et al.Multiple Sclerosis and Related Disorders|September 9, 2015
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case reportM H Harirchian, A Taalimi, B SiroosMultiple Sclerosis and Related Disorders|September 9, 2015
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitationsKatharina Schröder, David Finis, Jens Harmel, et al.Multiple Sclerosis and Related Disorders|September 9, 2015
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosisHeather J MacLean, Mohammad AbdoliMultiple Sclerosis and Related Disorders|September 9, 2015
Stopping immunomodulatory medications in MS: Frequency, reasons and consequencesW O Tobin, B G WeinshenkerMultiple Sclerosis and Related Disorders|September 9, 2015
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfactionAndrea Zimmer, Cornelia Bläuer, Michael Coslovsky, et al.Multiple Sclerosis and Related Disorders|September 9, 2015
Causes of death among persons with multiple sclerosisGary R Cutter, Jeffrey Zimmerman, Amber R Salter, et al.Multiple Sclerosis and Related Disorders|January 14, 2020
Do Secondary Progressive Multiple Sclerosis patients benefit from Computer- based cognitive neurorehabilitation? A randomized sham controlled trialLambros Messinis, Mary H Kosmidis, Grigorios Nasios, et al.Multiple Sclerosis and Related Disorders|January 18, 2020
Under-treated depression negatively impacts lifestyle behaviors, participation and health-related quality of life among older people with multiple sclerosisMichelle Ploughman, Elizabeth M Wallack, Tanaya Chatterjee, et al.Multiple Sclerosis and Related Disorders|November 20, 2020
Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of IranNegar Molazadeh, Farnam Mohebi, Davar Altafi, et al.Pageof 506